Form4insider filings, from the source

Insider · CIK 0001701247

Helen Louise Collins

Files at: ELVN, KURA, FPRX. On EDGAR ↗

1M3M6M1Y2YAll datashares as filed — not split-adjusted
Open-market buys & salesbuys $0 · 0sales $1.0M · 4net −$1.0M
$10k$10k$100k$100k$1M$1MbuyssalesJun 16Jul 1Jul 17Aug 2Aug 17Sep 2Sep 18

Reported trades — common stock

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Sep 17, 2026 SForm 4 →Sep 21, 5:22 pm EDTEnliven Therapeutics, Inc.ELVN5,000$50.35$251,75425,000−16.7%10b5-1
Sep 17, 2026 MForm 4 →Sep 21, 5:22 pm EDTEnliven Therapeutics, Inc.ELVN5,000$2.48$12,40030,000—10b5-1
Aug 17, 2026 SForm 4 →Aug 19, 4:16 pm EDTEnliven Therapeutics, Inc.ELVN5,000$58.59$292,93125,000−16.7%10b5-1
Aug 17, 2026 MForm 4 →Aug 19, 4:16 pm EDTEnliven Therapeutics, Inc.ELVN5,000$2.48$12,40030,000—10b5-1
Jul 17, 2026 SForm 4 →Jul 21, 5:23 pm EDTEnliven Therapeutics, Inc.ELVN5,000$52.67$263,37325,000−16.7%10b5-1
Jul 17, 2026 MForm 4 →Jul 21, 5:23 pm EDTEnliven Therapeutics, Inc.ELVN5,000$2.48$12,40030,000—10b5-1
Jun 17, 2026 SForm 4 →Jun 22, 5:11 pm EDTEnliven Therapeutics, Inc.ELVN5,000$43.80$219,01725,000−16.7%10b5-1
Jun 17, 2026 MForm 4 →Jun 22, 5:11 pm EDTEnliven Therapeutics, Inc.ELVN5,000$2.48$12,40030,000—10b5-1
Feb 25, 2019 AFForm 4 →Feb 27, 7:58 pm ESTFIVE PRIME THERAPEUTICS INCFPRX11,177$11.95$14,06539,794— plan?
Feb 5, 2019 FForm 4 →Feb 7, 5:21 pm ESTFIVE PRIME THERAPEUTICS INCFPRX3,196$11.43$36,53030,971— plan?
Sep 28, 2018 AFForm 4 →Oct 2, 6:43 pm EDTFIVE PRIME THERAPEUTICS INCFPRX5,750$13.92$26,53234,167— plan?
Sep 1, 2018 FForm 4 →Sep 5, 11:22 am EDTFIVE PRIME THERAPEUTICS INCFPRX496$14.00$6,94432,229— plan?
Jun 23, 2018 FForm 4 →Jun 26, 8:16 pm EDTFIVE PRIME THERAPEUTICS INCFPRX1,240$17.38$21,55132,725— plan?
Mar 20, 2018 FForm 4 →Mar 22, 2:50 pm EDTFIVE PRIME THERAPEUTICS INCFPRX827$16.26$13,44733,965— plan?
Feb 5, 2018 FForm 4 →Feb 7, 2:05 pm ESTFIVE PRIME THERAPEUTICS INCFPRX1,048$18.42$19,30423,732— plan?
Sep 1, 2017 FForm 4 →Sep 6, 7:11 pm EDTFIVE PRIME THERAPEUTICS INCFPRX376$34.34$12,91224,780— plan?
Jun 23, 2017 AFForm 4 →Feb 28, 2018, 7:18 pm ESTFIVE PRIME THERAPEUTICS INCFPRX7,940$31.24$29,36634,792— plan? late
Apr 24, 2017 AForm 4 →Apr 26, 4:36 pm EDTFIVE PRIME THERAPEUTICS INCFPRX1,250——25,156— plan?
Mar 20, 2017 AForm 4 →Mar 22, 5:45 pm EDTFIVE PRIME THERAPEUTICS INCFPRX3,750——23,906— plan?

Reported trades — derivatives (options, RSUs, warrants)

TradeReported (ET)CompanySharesAvg priceTotalOwned afterΔ stakeFlags
Sep 17, 2026 MForm 4 →Sep 21, 5:22 pm EDTEnliven Therapeutics, Inc.ELVN5,000——106,268—10b5-1
Aug 17, 2026 MForm 4 →Aug 19, 4:16 pm EDTEnliven Therapeutics, Inc.ELVN5,000——111,268—10b5-1
Jul 17, 2026 MForm 4 →Jul 21, 5:23 pm EDTEnliven Therapeutics, Inc.ELVN5,000——116,268—10b5-1
Jun 17, 2026 MForm 4 →Jun 22, 5:11 pm EDTEnliven Therapeutics, Inc.ELVN5,000——121,268—10b5-1
Jun 4, 2026 AForm 4 →Jun 4, 6:30 pm EDTKura Oncology, Inc.KURA35,000——35,000—
Feb 25, 2019 AForm 4 →Feb 27, 7:58 pm ESTFIVE PRIME THERAPEUTICS INCFPRX58,000——58,000—
Feb 26, 2018 AForm 4 →Feb 28, 7:18 pm ESTFIVE PRIME THERAPEUTICS INCFPRX50,000——50,000—
Mar 20, 2017 AForm 4 →Mar 22, 5:45 pm EDTFIVE PRIME THERAPEUTICS INCFPRX22,500——91,500—